<DOC>
	<DOCNO>NCT01593774</DOCNO>
	<brief_summary>The purpose study determine whether melatonin prevent metabolic side effect olanzapine weight gain , elevate glucose concentration lipid abnormality .</brief_summary>
	<brief_title>Melatonin Prevention Metabolic Side Effects Olanzapine</brief_title>
	<detailed_description>Atypical antipsychotic include olanzapine associate significant metabolic side effect . Animal study suggest melatonin might prevent olanzapine-associated side effect . Melatonin safe widely use sleep-promoting complement , associate side effect see use drug metformin .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Age 1865 year First episode schizophrenia ( DSMIVTR ) Ability take medicine orally Eligible start olanzapine Married woman reproductive age History take olanzapine recent 3 month History allergy intolerance olanzapine History significant head trauma ( cause loss consciousness 5 minute neurological cognitive sequel ) Liver , kidney , cerebrovascular cardiovascular disease Diabetes , metabolic syndrome Cancer Using antiepileptic ( benzodiazepine sleep ) , antihypertensive , anticoagulant , antiplatelet drug Using inhibitor stimulant hepatic isoenzymes metabolize melatonin olanzapine ( e.g . omeprazole . rifampin , fluvoxamine , ciprofloxacin , carbamazepine , modafinil ) Delirium Need administration antipsychotic Substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Melatonin</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Metabolic side effect</keyword>
	<keyword>Psychosis</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Weight gain</keyword>
	<keyword>Diabetes</keyword>
</DOC>